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Purpose: The most quoted literature on arteriographic complications is based on 
self-reports collected uring the mid 1970s. We sought o determine whether those results 
remain valid despite changes in arteriographic practice and whether patient subgroups at 
increased risk could be identified. 
Methods: Five htmdred forty-nine consecutive patients were examined after arteriography 
and twice over 72 hours. Patients were t lephoned atleast 2 weeks later to identify delayed 
complications. The sample was divided into two groups to allow independent validation 
of suspected prognostic factors. 
Results: The rate of major complications was 2.9% (16/549), but varied from 0.7% to 9.1% 
among three strata of relative risk. Rates were highest in patients tudied for suspected 
aortic dissection, mesenteric schemia, gastrointestinal bleeding, or symptomatic carotid 
artery stenosis and lowest in patients with trauma or aneurysmal disease. Patients tudied 
for claudication or limb-threatening ischemia had intermediate risk (2.0%). Within these 
strata, congestive heart failure and furosemide use were the only variables independently 
associated with a significantly increased complication rate. 
Conclusions: Previous reports have overestimated the risk of arteriography for trauma or 
aneurysm but substantially underestimate he risk for patients with other common 
conditions. Such stratified complication rates are essential to understand relative osts and 
benefits of arteriography and other vascular imaging modalities in specifie clinical 
situations. (J VASC SURG 1995;22:787-94.) 
Peripheral arteriography plays a pivotal role in the 
diagnosis and management of a wide variety of 
disorders, including extremity and mesenteric isch- 
emia, gastrointestinal b eeding, hemoptysis, aortic 
dissection, arterial injuries, and carotid artery disease. 
Despite this broad application, arteriography is often 
regarded as expensive, hazardous, and arduous. 
Although the development of noninvasive vascular 
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imaging tests has been driven by a desire to avoid the 
dangers of conventional rteriography, 1,2the causes 
and incidence of these complications have seldom 
been investigated. No prospective studies describing 
the expected complication rate of peripheral arteri- 
ography have been published uring the past decade, 
despite many procedural improvements, including 
the selective use of low osmolar contrast media, a 
reduction in the caliber of angiographic atheters, 
intraarterial digital subtraction arteriography, and 
the introduction of outpatient arteriography. 
The usually quoted rates of complications for 
arteriography come from two relatively old reports. 
In 1978 Sigstedt and Lunderquist 3 prospectively 
studied 1217 adult patients, for whom physicians 
completed a standardized form after the examination, 
and visited the following day. Despite many details 
about an array of complications, rates were not 
specifically cited for overall complications or for those 
that had an impact on patient care or outcomes. In 
1981 Hessel et al.4 mailed questionnaires to radiolo- 
gists at 2066 hospitals and calculated an overall major 
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complication rate of 1.9% from the 25% response 
rate of 514 radiologists. 
Despite wide acceptance of these estimates, s7
most experienced angiographers have noted that 
certain types ofprocedures, such as arch aortography 
for patients with trauma, are associated with a 
relatively low complication rate, whereas others, like 
selective carotid arteriography, seem to have more 
frequent adverse vents. Differing complication rates 
have never been documented but would be important 
for current patient care and for the assessment of
emerging noninvasive vascular imaging modalities. 
Becanse competing imaging technologies such as 
magnetic resonance angiography and color-flow 
ultrasonography taust be appraised with an objective 
understandlng of the costs of the tests they are 
intended to replace, the absence of data on compli- 
cation rates might inappropriately accelerate or 
impede the acceptance of newer modalities. 
Our goal in this research was to measure, in a 
rigorous, prospective fashion, the complication rate 
associated with peripheral arteriography in contem- 
porary practice. We sought to determine whether 
certain arteriographic procedures were consistently 
either more hazardous or safer than a single, overall 
risk estimate might suggest. Similarly we hoped to 
learn whether analysis of preprocedural patient char- 
acteristics might alone identify subgroups ofpatients 
at increased risk of arteriographic complications. The 
hope was that patients and their physicians could be 
given a more accurate assessment of the risks 
associated with a selected procedure. 
PATIENTS AND METHODS 
Patients. During a 6-month interval, 556 pa- 
tients were referred for 607 non-coronary, non- 
intracerebral arteriograms atthe Massachusetts Gen- 
eral Hospital; all patients were enrolled in this 
prospective cohort. When informed consent was 
obtained for the procedure, the physician used a 
standardized data collection form to record informa- 
tion about demographic characteristics, medlcal his- 
tory, prescription medications, allergies, and habits 
such as smoking and alcohol consumption. 
In 47 patients who received more than one 
arteriogram, only the first examination is included 
in this analysis to avoid exaggeration f the impact 
of particular patient characteristics on the compli- 
cation rate. Five patients receiving urokinase therapy 
were excluded from further analysis becanse throm- 
bolysis procedures, which involve prolonged arterial 
catheterization during the administration of clot- 
dissolving drugs, have a completely different risk- 
benefit ratio than diagnostic arteriography. 
Angiographic technique and periprocedural 
care. The attending angiographer was responsible 
for selection of puncture site, catheter sizes, radio- 
graphic contrast agents, and volume of contrast 
administered. Information about each of these vari- 
ables was recorded for every patient. According to 
department guidelines, low osmolar ("non-ionic") 
contrast agents were used in elderly paUents or those 
with previous contrast allergy or congesUve heart 
fallure. At the conclusion of every procedure, the 
puncture site was compressed for at least 15minutes , 
and hemostasis was achieved by use of manual 
compression alone. All inpatients received overnight 
hydration before scheduled procedures and outpa- 
tients were given specific instrucuons for oral hydra- 
tion. All patients were given intravenous fluids for at 
least 6 hours after completion of the arteriogram, and 
it was our pollcy to administer intravenous mannitol 
(12.5 to 25 gin) and furosemide (20 to 40 mg) to all 
paUents with a preprocedure creaunine of 1.5 mg/dl 
or greater. 
Follow-up methods. Presence and details of any 
complicauon before departure from the radiology 
department were recorded, and all pafients were 
interviewed and examined twice during a 72-hour 
period after the angiographic procedure. For all 
available paUents, the second examination occurred 
between 3 and 12 hours after the procedure, and 
another visit was made on the next working day 
between 36 and 72 hours after the procedure. 
Discharged patients, or those undergoing outpatient 
procedures were interviewed by telephone. Two 
physical examinations were completed for 540 sub- 
jects (98%), and 441 patients (80%) were available 
for all three visits. Patients with identified complica- 
Uons were regularly monitored to determine both 
severity and clinical significance. All inpatients re- 
ceived aily blood urea nitrogen and serum creatinine 
determinations for the next two mornings after 
angiographic study. 
For all patients, long-term follow-up informa- 
tion was sought between 14 days and 3 months after 
the angiographic procedure. Patients till in hospital 
were visited, interviewed, and examined, and dis- 
charged patients were interviewed by telephone. 
Direct contact was accomplished with 407 patients 
(74%), but information was sometimes obtained 
from immedlate family or caretakers (n = 105, 
19%). Further information on patients who could 
not be examined personally or who could not be 
contacted by telephone was obtained by review of 
hospital, outpatient, and private office charts (n = 
37, 7%). Immediate and long-term follow-up in- 
formation of this kind was obtained with these 
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methods for 549 of 551 eligible subjects (99.6%); 
the other two patients left the Boston area and were 
unavailable for interview or physical examination. 
Definitions of complications. A complication 
was classified as major if it led to operative or 
transcatheter repair, permanent morbidity, a blood 
transfusion, or delay of an urgent surgical procedure. 
Minor complications were defined as immediately 
correctable vents that required additional, unex- 
pected therapy; for example, puncture site bleeding 
rectified with additional compression. Nonsignificant 
complications were adverse occurrences that were 
clearly related to the angiographic procedure, such as 
a groin ecchymosis or transient nausea, but that 
required no additional intervention and did not alter 
the patient's hospital course. 
The evaluation of contrast-induced renal insuffi- 
ciency required special consideration. Because pa- 
tients discharged from hospital or who underwent 
outpatient arteriography were not available for 
follow-up tests of kidney function, alterations in 
blood urea nitrogen and creatinine alone could not be 
used to define renal complications without biasing 
the results in favor of symptom-free patients who 
missed follow-up testing. Among patients undergo- 
ing the same type of arteriographic study, those 
discharged home and unavailable for follow-up blood 
tests would be assumed to have fewer complications, 
even if their clinical courses were in fact identical to 
those patients who remained in hospital (detection 
biasS), simply because as a group they would have 
fewer abnormal blood test results. For this reason, 
only renal insufficiency with clinical manifestations, 
such as oliguria or fluid overload, was objectively 
identified as a complication. 
Types of  complications. Arterial dissections, 
thromboses, groin hematomas, and puncture site 
bleeding were considered types of vascular injuries. 
Patients who had acute onset of urticaria, hypoten- 
sion, or laryngeal edema after administration of 
iodinated radiographic ontrast were classified as 
having "contrast allergies." Less commonly observed 
complications, including periprocedural angina pec- 
toris, neurologic injuries (e.g., numbness in distri- 
bution of the lateral femoral cutaneous nerve), and 
vasovagal episodes were grouped together in an 
"other complications" category. Each patient here- 
fore was coded as having had (1) no complication, 
(2) a vascular injury, (3) contrast allergy, (4) 
contrast-induced ki ney failure, or (5) other compli- 
cation. 
Statistical methods. In accordance with the 
customary procedure for validating predictive sys- 
tems, 9the 549-member cohort was randomly divided 
into a "training" set (n = 274) and a separate 
"testing" set (n = 275). The two groups were similar 
in age, sex, types of procedures performed, and 
overall complication rate (Table I). For categorical 
partitions age was classified in decades as less than 30 
years, 30 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 
79, and 80 years or older. 
The incidence of clinically significant complica- 
tions observed in the training set is described in 
Table II. On the basis of these observations, ar- 
teriographic examinations with similar complication 
rates in the training set were organized into three 
ordinal groups, designated as type 1 (lowest risk), 
type 2 (intermediate risk), and type 3 (highest 
observed complication rate). The ascending gradient 
in complication rates for the three qualitatively 
ordered groups was statistically significant according 
to both the chi-squared test for linear trend and its 
modification proposed by Bartholomew. m The va- 
lidity of this classification was confirmed by similar 
and statistically significant results in the independent 
testing set. 
In the next analytic step, to identify features of the 
training sample that might have predisposed to 
angiographic omplications, all demographic and 
clinical variables were checked with contingency table 
analyses. Two variables- history of congestive heart 
failure (CHF) and current use of furosemide-were 
significantly associated with complications but iden- 
tified nearly identical populations. The two variables 
were therefore consolidated into a single variable 
("CHF or furosemide use") that was considered 
positive if either factor was present. 
Individual baseline state features significantly 
associated with either major or minor complications 
(p < 0.10, Fisher's exact est) were entered into a 
logistic regression model to determine which char- 
acteristics, when examined in the multivariable con- 
text, maintained their impact on the complication 
rate. Diabetes mellitus, angiographic catheter caliber, 
type of contrast administered, contrast volume, and 
grams of iodine received were not associated with 
complications in the training and testing sets but are 
logical risk factors for arteriographic omplica- 
tions n'12 and were therefore included in the list of 
candidate covariates receiving the logistic regression 
analysis. The Charlson measure of comorbidity, 13
which had been calculated from data collected about 
each patient, was not associated with an increased risk 
of angiographic complications and was not retained 
for subsequent analyses. Separate logistic regression 
analyses were performed on the entire cohort by use 
of a forward stepwise approach, with both clinically 
significant complications (major and minor), and 
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Table I. Baseline patient characteristics (no. [%] ofpatients) 
Testing sample Total 
Training sample (n = 274) (n = 275) (n = 549) 
Age in years (mean ___ SD) 59 + 17 59 --- 18 59 -+ 18 
Women 105 (38) 88 (32) 193 (35) 
Patient condition 
Good 208 (74) 212 (77) 420 (75) 
Fair 56 (20) 49 (18) 105 (19) 
Critical 16 (5) 16 (5) 32 (5) 
Comorbidity index (mean 4- SD) 1.7 + 1.2 1.7 -+ 1.3 1.7 _+ 1.3 
Arteriographic studies « 
Type 1 71 (26) 76 (28) 147 (27) 
Type 2 177 (65) 170 (62) 347 (63) 
Type 3 26 (10) 29 (11) 55 (10) 
History 
Allergies 72 (26) 55 (20) 127 (23) 
Contrast allergy 5 (2) 6 (2) 11 (2) 
Congestive heart failure ~ 18 (7) 16 (6) 34 (6) 
Diabetes 52 (19) 31 (11) 83 (15) 
Hypertension 117 (43) 107 (39) 224 (41) 
Coronary artery disease 66 (24) 66 (24) 132 (24) 
Stroke 11 (4) 8 (3) 19 (4) 
Chronic kidney failure 10 (4) 10 (4) 20 (4) 
Medications 
Beta-blockers 47 (17) 58 (21) 105 (19) 
Calcium channel blockers • 43 (16) 52 (I9) 95 (17) 
ACE Inhibitors 26 (10) 32 (12) 58 (11) 
Nitrates 37 (14) 35 (13) 72 (13) 
Digoxin 28 (10) 34 (12) ö2 (11) 
Furosemide ~ 27 (10) 24 (9) 51 (9) 
Warfarin 15 (ö) 22 (8)  37 (7) 
Thiazide Diuretics 46 (17) 46 (I7) 92 (17) 
Antiplatelet drugs 64 (23) 46 (17) 110 (20) 
H2-receptor antagonists 21 (8) 31 (11) 52 (10) 
Insulin 17 (6) 16 (6) 33 (6) 
Oral hypoglycemics 21 (8) 10 (4) 31 (6) 
Site of catheter introduction 
Retrograde femoral artery 263 (96) 264 (96) 527 (96) 
Other l l  (4) l l  (4) 22 (4) 
*Variables with significant bivariate association with complications (p < 0.10) in both training and testing samples. 
ùwith major complications alone as outcome mea- 
sures. The Statistical Analysis System software (SAS 
Institute, Inc., Cary, N.C.) was used for all statistical 
analyses. 
RESULTS 
Rates of complications. There were 16 major 
and 35 minor complications, for major and total 
complication rates of 2.9% and 9.3%, respectively 
(Table III). The major complications included four 
vascular injuries (two severe hematomas and two 
femoral artery thromboses), two severe contrast 
reactions, eight cases ofsevere contrast-induced r nal 
insufficiency, and transient ischemic attacks in two 
patients (Table IV). The 35 mlnor complications 
included 15 vascular injuries (5 hematomas, 4 vessel 
thromboses that did not require intervention, 5
bleeding episodes, 1 case of peripheral cholesterol 
embolization), 2 lesser contrast reactions that re- 
quired therapy, 4 cases of mild contrast-induced r nal 
insufficiency, 6 transient cardiovascular events (in- 
cluding angina, CHF, and vasovagal episodes), 1 case 
of transient mental status changes after an arm 
arteriogram, and 7 miscellaneous adverse outcomes 
(primarily persistent pain in the distribution of the 
lateral femoral cutaneous nerve). 
This series included three pelvic embolizations for 
traumatic bleeding, five tumor embolizations, and 
four pitressin infusions to control gastrointestinal 
bleeding. There were also 10 common or cxternal 
iliac artery and t-wo superficial femoral artery angio- 
plasties. Be,ause there were no major complications 
during these 24 cases, and be,ause the minor compli- 
cation rates of these subjects (three of 24) did not 
differ significantly from other patients receiving simi- 
lar types of arteriography, these interventional proce- 
dures were retained in the sample for all analyses. 
Gradient in complications. As shown in 
Table III a significant gradient in the complication 
rate was observed among types of arteriographic 
studies. In the training set, major complications 
occurred in none of 71 type I studies, but in 4 of 
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Table II. Arteriographic studies grouped according to incidence of clinically significant 
complications observed in training set (no. [%] of patients) 
Complication severity 
n Major Major and minor 
Type 1 arteriography for arterial injury, aneurysm, or anomaly 
Trauma 26 0 (0%) 
Preoperative anatomy for aneurysmal disease 28 0 (0%) 
Preoperative anatomy for other indications 17 0 (0%) 
Type 2 arteriography for arterial occlusion or encasement 
Arteriography prior to cancer surgery 38 0 (0%) 
Suspected renal artery stenosis 22 0 (0%) 
Claudication 55 2 (4%) 
Limb-threatening ischemia 46 2 (4%) 
Asymptomatic carotid bruit ló 0 (0%) 
Type 3 arteriography in patients at risk of death or stroke 
Symptomatic carotid bruit I4 1 (7%) 
Gastrointestinal bleeding or mesenteric schemia 8 0 (0%) 
Suspected aortic dissection 4 1 (25%) 
0 (0%) 
1 (4%) 
0 (0%) 
4 (11%) 
3 (14%) 
4 (7%) 
3 (7%) 
3 (19%) 
4 (29%) 
3 (33%) 
1 (25%) 
177 (2.3%) type 2 and 2 of 26 (7.7%) type 3 
examinations. The trend of the gradient in these 
proportions was significant (chi-squared, p < 0.05). 
The same trend was noted and statistically con- 
firmed in the testing set where the rates of major 
complication were 1.3% (1 of 76) among type 1 
studies, 3.5% (6 of 170) among type 2, and 10.3% 
(3 of 29) among type 3 studies. 
For the combined rate of major and minor (that 
is, clinically significant) complications, the training 
and testing samples howed aless impressive but still 
statistically significant trend. In the training set, the 
combined rate of complications was 1.4% (1 of 71) 
among the type 1 studies, 9.6% (17 of 177) in type 
2, and 30.8% (8 of 26) in type 3 examinations. In the 
testing set, the combined rates were 1.3% (1 of 76) 
in type 1 studies, 11.8% (20/170) in type 2, and 
13.7% (4/29) in type 3 studies. The gradient in the 
proportions observed between groups was also 
significant (chi-squared, p < 0.05). 
Severity of complications. All of the vascular 
injuries that required surgical repair or transfusion 
occurred among patients undergoing arteriography 
for indications relating to peripheral atherosclerosis 
(type 2). Patients referred for type 3 smdies were 
most likely to have other types of complications, 
including contrast-induced ki ney failure (Table IV). 
Patients who had axillary or antegrade punctures 
were no more likely to have complications than were 
others who underwent type 2 studies (0 of 22 vs 10 
of 325). 
Impaet of CHF or furosemide use. A separate 
analysis (Table V) indicates that the composite 
variable of "CHF or furosemide use" had a separate 
effect on the complication rate for each type of 
arteriographic smdy. Patients with a history of CHF 
or current furosemide use had essentially the same 
complication rate as patients without those charac- 
teristics in the next higher-risk group of studies. For 
example, patients with CHF or furosemide use who 
underwent type 2 arteriography ad major and total 
complication rates of 6% and 17%, compared with 
5% and 16% in patients without hose characteristics 
undergoing type 3 arteriography. 
Multivariable analysis. The results of the step- 
wise logistic regression are presented in Table VI. 
The type of arteriography and the composite "CHF 
or furosemide use" measure were the only variables 
that met the 0.05 significance l vel for entry into the 
model, with either major complications or both ma- 
jor and minor complications a the outcome or "de- 
pendent" variables. These findings confirm the results 
obtained by categorical partitioning and suggest that 
when other factors significanfly associated with ad- 
verse events in the bivariate analysis are adjusted for, 
movement between groups of arteriographic studies, 
such as from type 1 to type 2, more than triples the 
risk of a major complication. Similarly, the presence 
of a history of CHF or current use of furosemide was 
associated with a fourfold increase in the risk of a 
major complication. 
DISCUSSION 
The complications ofperipheral rteriography do
not seem to occur in purely random fashion. In the 
three groups of arteriographic studies with signifi- 
cantly different complication rates, the indications for 
the study remained significant predictors of compli- 
cations, regardless of the impact of baseline charac- 
teristics uch as medical history or medications. Like 
Moore et al.,14 we found that increasing age, a history 
of contrast allergy, diabetes mellitus, or chronic 
kidney failure were not associated with an indepen- 
dent increase in risk of arteriographic complications. 
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Table III. Rates of clinically significant complications* 
n No. 
Complication severity 
Major? 
(%) (95% ci) No. 
Major and minor¢ 
(%) (9s% c~) 
Training sample 
Type 1 71 0 (0.0) 
Type 2 177 4 (2.3) 
Type 3 26 2 (7.7) 
All 274 6 (2.2) 
Testing sample 
Type 1 76 1 (1.3) 
Type 2 170 6 (3.5) 
Type 3 29 3 (10.3) 
All 275 10 (3.6) 
Entire cohort 
Type 1 147 1 (0.7) 
Type 2 347 10 (2.9) 
Type 3 55 5 (9.1) 
All 549 16 (2.9) 
(0-5.0) 
(0.6-5.7) 
(0.9-24.8) 
(0.8-4.7) 
(0.0-7.1) 
(1.3-7.5) 
(2.2-27.1) 
(1.8-6.6) 
(0.0-3.7) 
(1.4-5.2) 
(3.0-19.9) 
(1.7-4.7) 
1 
17 
8 
26 
1 
20 
4 
25 
2 
37 
12 
51 
(1.4) (0.0-7.5) 
(9.6) (5.7-14.9) 
(30.8) (14.3-51.5) 
(9.5) (ö.3-13.6) 
(1.3) (0.0-7.1) 
(11.8) (7.3-17.6) 
(13.8) (3.9-31.4) 
(9.1) (6.0-13.1) 
(1.4) (0.2-4.8) 
(10.7) (7.6-11.4) 
(21.8) (11.8-34.9) 
(9.3) (7.0-12.0) 
CI, Confidence interval. 
*Types of arteriography are defined in Table II. 
~-p < 0.05, Bartholomew's ×2. 
:~p < 0.005, Bartholomew's X 2. 
Table IV. Nature of clinically significant complications according to type of arteriographic study* 
No. (%) of patients 
n Vascular injury Contrast allergy Acute kidney failure Other 
Major complications 
Type 1 147 0 (0) 1 (1) 0 (0) 0 (0) 
Type 2 347 4 (1) 0 (0) - 6 (2) 0 (0) 
Type 3 55 0 (0) 1 (2) 2 (4) 2 (4) 
Total 549 4 (1) 2 (0) 8 (1) 2 (0) 
All clinically significant complications 
Type 1 147 1 (1) 1 (1) 0 (0) 0 (0) 
Type 2 347 17 (5) 2 (1) 10 (3) 8 (2) 
Type 3 55 1 (2) 1 (2) 2 (4) 8 (15) 
Total 549 19 (4) 4 (1) 12 (2) 16 (3) 
«Types of arteriography are defined in Table II. Vascular injuries included hematomas, dissections and pseudoaneurysms. Other category 
includes cardiovascular (angina, vasovagal) and neurologic events. 
With a simple classification system based only on the 
type of arteriogram and the presence or  absence of 
CHF, we distinguished groups ofpatients for whom 
the extremes ofrisk of a major complication differed 
by more than 30-fold. 
The total rate of major complications observed in 
this study (2.9%) is relatively similar to the 1.9% 
reported by Hessel et al.,4 but our results uggest that 
meaningful comparisons between published series 
may be difficult or impossible without knowledge of 
the types of patients and procedures included. For 
example, a predominance of type 1 procedures might 
lower the overall ("mean") complication rate in a 
report without affecting the actual morbidity rate 
within subgroups. 
Previous studies of peripheral arteriographic 
complications and many fundamental tenets of the 
practice of peripheral arteriography may be mistak- 
enly based on the assumption that all arteriograms 
have the same risk. For example, Hessel et al. 4 
reported that the complication rate for catheter 
placement via the axillary artery was almost wice that 
observed after transfemoral rtery studies (3.3% vs 
1.7%). Because axillary artery puncture is almost 
exclusively used in patients with pulseless lower 
extremities undergoing type 2 or 3 examinations, is 
our results suggest hat the maneuver can only be 
meaning~ally compared with femoral artery puncture 
in patients undergoing similar arteriographic studies. 
In "high risk" procedures, reputed to be more 
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Table V. Cross-stratification f complication data according to presence of CHF or furosemide use 
at baseline s 
No. (%) of patients 
Training sample 
CHF or furosemide use present 
Testing sample 
CHF or furosemide use present 
Entire cohort 
CHF or furosemide use present 
No Yes No Yes No Yes 
Major complications 
Type 1 0/66 (0) 0/5 (0) 1/69 (1) 0/7 (0) 1/135 (1) 0/12 (0) 
Type 2 2/137 (2) 2/40 (5) 3/131 (2) 3/39 (8) 5/268 (2) 5/79 (6) 
Type 3 1/21 (5) 1/5 (20) 1/22 (5) 2/7 (29) 2/43 (5) 3/12 (25) 
Total 3/224 (1) 3/50 (6) 5/222 (2) 5/53 (9) 8/446 (2) 8/103 (8) 
All clinically significant compli- 
cations 
Type 1 0/66 (0) 1/5 (20)1/69 (1) 0/7 (0) 1/135 (1) 1/12 (8) 
Type 2 12/137 (9) 5/40 (13) 12/131 (9) 8/39 (21) 24/268 (9) 13/79 (17) 
Type 3 5/21 (24) 3/5 (60) 2/22 (9) 2/7 (29) 7/43 (16) 5/12 (42) 
Total 17/224 (8) 9/50 (18) 15/222 (7) 10/53 (19) 32/446 (7) 19/103 (18) 
~Types of arteriograptty are defined in Table II. 
Table VI. Results of stepwise logistic regression 
Outcome Variables elected for inclusion Regression coefficient (13) SE OR (95% CI) 
Major complications Study 1.24 0.47 3.5 (1.4-8.7) 
CHF or furosemide use 1.39 0.52 4.0 (1.5-11.0) 
All significant complications Study 1.20 0.28 3.3 (I.9-5.7) 
CHF or furosemide use 0.94 0.32 2.6 (1.4-4.8) 
SE, Standard error of regression coefficient ([3); OR, odds ratio (calculated ase~); CI, confidence interval. 
hazardous than transfemoral rteriography, 4'16 our 
results for axillary artery punctures and "antegrade" 
femoral artery punctures (where the catheter is 
directed from the groin toward the foot rather than 
the head), showed a complication rate (0 of 22) that 
did not differ significantly from other type 2 studies 
(10 of 325). Thus the high-risk procedures, although 
possibly associated with unique or more severe risks 
as a result of particular anatomic onsiderations, may 
be no more hazardous than femoral arteriography in 
similar patients. 
Limitations and strengths. Preprocedural in- 
formation alone predicts only a portion of the 
observed adverse vents and intraprocedural factors 
presumably also affect patient outcomes.17 Although 
catheter caliber 18 and volume of contrast injected 14 
may have little influence on complications, certain 
types of arteriography carry unique risks. For ex- 
ample, minute thrombi arising from arteriographic 
catheters 19'2° are almost certain to remain silent in 
most parts of the body but may have catastrophic 
effects when injected into the carotid arteries. 
Despite the relatively low number of complica- 
tions observed in this cohort, we were able to confirm 
the statistical validity of our prognostic system in two 
independent samples. In addition to analyzing the 
types of arteriography, other strengths of this study 
are its prospective design and almost universal 
follow-up (99.6%). Most other studies have relied on 
chart review 17 or self-administered questionnaires, 4 
which are less likely to identify complications than 
direct examination and interviews with patients. 
Unlike other authors, we also measured the occur- 
rence of "minor" complications, which by definition 
do not require surgery or alter the clinical course but 
may be very distressing to patients. 
Implications. The observation that some groups 
of patients are at increased risk is significant for two 
reasons. By understanding the hazards to which 
patients are subjected, referring physicians and an- 
giographers can make better clinical decisions and can 
provide patients and their families with the facts 
needed to give a truly informed consent. Information 
of this type may also help define which patients or 
arteriographic studies are most suitable for outpa- 
tient procedures. 
Although the results reported here may seem 
alarming, the complication rates must be interpreted 
in context. Many patients in the highest risk category, 
that is, patients with CHF undergoing type 3 studies, 
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who exhibited major and combined complication 
rates of  25% and 42%, respectively, faced short-term 
mortal ity rates approaching 100% if conditions such 
as mesenteric ischemia or aortic dissection were not 
diagnosed and treated promptly.  For each patient 
and situation, physicians must  therefore consider if 
the incrcment of  information gained from the 
arteriogram warrants the risk. 
Finally, the assessment of  new technologies de- 
pends on a complete understanding of  existing 
methods and current practice. The scientific evalua- 
tion of  new "noninvasive" vascular imaging tests, for 
example, demands a careful synthesis o f  their infor- 
mation content or diagnostic yield (benefit) and their 
costs (financial and morbid)  relative to arteriography. 
Consequently, the threshold for accepting a new 
technology must be adjusted according to the type o f  
arteriography that it is intended to replace. It  is easier 
to propose replacing type 3 studies with an alternate 
test, even if it offers slightly less accurate diagnostic 
information than type 1 examinations. 
We believe that these findings substantiate Fuchs 
and Garber's 21 proposal that accepted technologies 
be reassessed intermittently. Arter iography has been 
in common use for several decades, but the causes and 
distribution o f  arteriographic complications are still 
incompletely described, and much remains to be 
learned about this still-indispensable procedure. Al- 
though arteriographic methods and noninvasive 
vascular imaging modalities continue to evolve, 
recognition o f  differential complication rates is es- 
sential to ensure that these new procedures are 
studied and compared in similar groups of  patients. 
After our results have been validated in other settings, 
physicians can better understand the balance o f  
benefit and risk in individual cases and can modify the 
causes of  arteriographic omplications or use alter- 
native diagnostic tests to improve the safety of  patient 
care. 
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